SPRAVATO® Therapy
Rapid Relief for Treatment-Resistant Depression
Discover SPRAVATO®: A New Hope for Treatment-Resistant Depression
Are you or a loved one struggling with depression that hasn't responded to traditional treatments?
SPRAVATO® might be the breakthrough you've been waiting for.
What is SPRAVATO®?
SPRAVATO® (esketamine) nasal spray is an innovative, FDA-approved treatment specifically designed for individuals with treatment-resistant depression. It's a game-changer, offering rapid relief when other medications haven't worked.
SPRAVATO® (esketamine) Nasal Spray is indicated, in conjunction with an oral antidepressant, for the treatment of:
• Treatment-resistant depression (TRD) in adults.
• Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.
Fast-Acting: Experience noticeable improvement in symptoms within hours, not weeks.
Clinically Proven: Backed by rigorous clinical trials demonstrating its effectiveness.
Convenient Administration: Administered in a safe, controlled environment under medical supervision.
Holistic Care: Integrated into a comprehensive treatment plan to ensure the best outcomes.
